Technical Analysis for ACON - Aclarion, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.19 | 0.54% | 0.00 |
ACON closed up 0.54 percent on Friday, November 1, 2024, on 45 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| 50 DMA Resistance | Bearish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Fell Below 20 DMA | Bearish | 0.54% | |
| Fell Below 50 DMA | Bearish | 0.54% | |
| Wide Bands | Range Expansion | 0.54% | |
| 20 DMA Support | Bullish | -6.47% | |
| 50 DMA Support | Bullish | -6.47% |
| Alert | Time |
|---|---|
| Possible NR7 | about 22 hours ago |
| Possible Inside Day | about 22 hours ago |
| Down 1% | 1 day ago |
| Fell Below 20 DMA | 2 days ago |
| Down 10% | 2 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/28/2024
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Sector: Healthcare
Industry: Health Information Services
Keywords: Biotechnology Life Sciences Natural Sciences Software Application Biomarkers Healthcare Technology Spectroscopy Chemical Pathology
Classification
Sector: Healthcare
Industry: Health Information Services
Keywords: Biotechnology Life Sciences Natural Sciences Software Application Biomarkers Healthcare Technology Spectroscopy Chemical Pathology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.3984 |
| 52 Week Low | 0.1599 |
| Average Volume | 511,014 |
| 200-Day Moving Average | 0.50 |
| 50-Day Moving Average | 0.19 |
| 20-Day Moving Average | 0.19 |
| 10-Day Moving Average | 0.20 |
| Average True Range | 0.02 |
| RSI (14) | 48.72 |
| ADX | 29.5 |
| +DI | 20.87 |
| -DI | 11.62 |
| Chandelier Exit (Long, 3 ATRs) | 0.18 |
| Chandelier Exit (Short, 3 ATRs) | 0.22 |
| Upper Bollinger Bands | 0.22 |
| Lower Bollinger Band | 0.16 |
| Percent B (%b) | 0.49 |
| BandWidth | 32.90 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.00 |
| MACD Histogram | 0.0008 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.20 | ||||
| Resistance 3 (R3) | 0.20 | 0.20 | 0.20 | ||
| Resistance 2 (R2) | 0.20 | 0.19 | 0.20 | 0.20 | |
| Resistance 1 (R1) | 0.19 | 0.19 | 0.19 | 0.19 | 0.20 |
| Pivot Point | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 |
| Support 1 (S1) | 0.18 | 0.18 | 0.18 | 0.18 | 0.17 |
| Support 2 (S2) | 0.18 | 0.18 | 0.18 | 0.17 | |
| Support 3 (S3) | 0.17 | 0.18 | 0.17 | ||
| Support 4 (S4) | 0.17 |
